🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Quotient Sciences-Miami, Inc
Start Date
2023-06-27
Trial ID
NCT05950906
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
The Phase 1 study described herein will evaluate the safety, tolerability, ...
Status
Recruiting
Location
Xencor Investigative Site
Start Date
2024-10-10
Trial ID
NCT06619990
This is a multi-center, randomized, double blind, placebo-controlled study ...
Status
Unknown
Location
The First Affiliated Hospital of Guangzhou Medical University
Start Date
2022-07-19
Trial ID
NCT06642961
Treatments Being Tested
The study is conducted in order to find out if repeated doses of the monocl...
Status
Completed
Location
Study Site
Start Date
2010-12
Trial ID
NCT01481493
The goals of this clinical study are to first learn more about safety and d...
Status
Recruiting
Location
Investigative Site
Start Date
2025-07-31
Trial ID
NCT07096193
Treatments Being Tested
This is a phase 1/2a double-blinded, placebo-controlled, dose-escalating st...
Status
Recruiting
Location
Liverpool Hospital
Start Date
2024-03-04
Trial ID
NCT06138743
Treatments Being Tested
This is an open-label extension study to Study 200622.In this study subject...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-11-13
Trial ID
NCT03306043
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of sin...
Status
Completed
Location
Anapharm
Start Date
2008-07
Trial ID
NCT00734240